Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-19

Clinical Trial Update: Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma [NA]

View source ↗

Summary

Clinical trial evaluating cord blood serum for glaucoma and other neurodegenerative ophthalmic diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cord Blood Serum (cord blood serum)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Glaucoma, Neuro-Degenerative Disease | NA | Status: COMPLETED